Quick Answer
Pharma-Bio Serv, Inc. reported Stockholders Equity of $11.91 million for the year ending 2025.
- Pharma-Bio Serv, Inc. showed a decrease of -13.1% in Stockholders Equity from 2024 to 2025.
- This data is from Pharma-Bio Serv, Inc.'s annual report (Form 10-K), filed with the SEC on January 29, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $8.24 million | Q1 2012: $9.32 million | Q2 2012: $10.53 million | Q3 2012: $11.76 million | Q1 2013: $14.13 million | Q2 2013: $15.49 million | Q3 2013: $16.78 million | Q1 2014: $18.74 million | Q2 2014: $19.08 million | Q3 2014: $19.66 million | Q1 2015: $20.68 million | Q2 2015: $21.05 million | Q3 2015: $21.50 million | Q1 2016: $22.30 million | Q2 2016: $22.42 million | Q1 2017: $21.45 million | Q2 2017: $21.14 million | Q3 2017: $21.04 million | Q1 2018: $18.17 million | Q2 2018: $18.02 million | Q3 2018: $18.72 million | Q1 2019: $20.69 million | Q2 2019: $21.36 million | Q3 2019: $21.79 million | Q1 2020: $21.13 million | Q2 2020: $21.80 million | Q3 2020: $22.58 million | Q1 2021: $21.29 million | Q2 2021: $21.55 million | Q3 2021: $23.84 million | Q1 2022: $17.43 million | Q2 2022: $15.89 million | Q3 2022: $16.15 million | Q1 2023: $16.99 million | Q2 2023: $15.67 million | Q3 2023: $16.19 million | Q1 2024: $14.16 million | Q2 2024: $13.95 million | Q3 2024: $13.69 million | Q4 2024: $13.72 million | Q1 2025: $12.00 million | Q2 2025: $12.12 million | Q3 2025: $11.93 million | Q4 2025: $11.91 million | Q1 2026: $10.24 million.
- Over the full 17 years of available data (2009 to 2025), Pharma-Bio Serv, Inc.'s Stockholders Equity has grown by 155.5%.
- Historical annual values: Fiscal year 2025: $11.91 million | Fiscal year 2024: $13.72 million | Fiscal year 2023: $16.13 million | Fiscal year 2022: $16.56 million | Fiscal year 2021: $18.91 million | Fiscal year 2020: $22.72 million | Fiscal year 2019: $20.61 million | Fiscal year 2018: $20.26 million | Fiscal year 2017: $20.75 million | Fiscal year 2016: $21.81 million | Fiscal year 2015: $21.96 million | Fiscal year 2014: $20.51 million | Fiscal year 2013: $18.05 million | Fiscal year 2012: $12.88 million | Fiscal year 2011: $8.24 million | Fiscal year 2010: $5.07 million | Fiscal year 2009: $4.66 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: